To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene DRAP1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
309 supporting clones for gene DRAP1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG719065 testis .a 1 to 712 1 to 711   tiling clone,   711/712
(99 %)
6 diff
(99.2 %id)
NM_006442.3   .a 5 to 1008 1 to 1004 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 1004/1004
(100 %)
0 diff
(100 %id)
BM737966 Ascites, stomach .a 21 to 334 1 to 314       314/314
(100 %)
0 diff
(100 %id)
BM763840 myeloma .a 21 to 527 7 to 513       507/513
(98 %)
7 diff
(98.7 %id)
BM841944 myeloma .a 21 to 563 7 to 549       543/549
(98 %)
7 diff
(98.8 %id)
BM781833 myeloma .a 21 to 560 7 to 544       538/544
(98 %)
6 diff
(98.9 %id)
BM764137 myeloma .a 23 to 578 1 to 554       554/554
(100 %)
1 diff
(99.9 %id)
BQ430246 epithelioid carcinoma, Pancreas .a 35 to 582 1 to 551       551/923
(59 %)
5 diff
(99.5 %id)
AA158294 Pancreas .a 38 to 322 1 to 284       284/284
(100 %)
7 diff
(97.6 %id)
BM006824 ductal carcinoma, cell line, Pancreas .a 39 to 489 1 to 449   fully sequenced,   449/449
(100 %)
3 diff
(99.4 %id)
BM006728 ductal carcinoma, cell line, Pancreas .a 39 to 489 1 to 456   fully sequenced,   456/456
(100 %)
6 diff
(98.7 %id)
BM912607 amelanotic melanoma, cell line, skin .a 39 to 574 1 to 536       536/1139
(47 %)
4 diff
(99.7 %id)
BU169147 ductal carcinoma, cell line, Pancreas .a 40 to 611 26 to 604       576/989
(58 %)
21 diff
(97.9 %id)
TI_59395310   .a 40 to 489 109 to 556   fully sequenced,   448/448
(100 %)
2 diff
(99.6 %id)
TI_59395820   .a 40 to 489 57 to 511   fully sequenced,   455/455
(100 %)
5 diff
(99.0 %id)
BU179713 ductal carcinoma, cell line, Pancreas .a 41 to 910 1 to 884 A167G T174D P175T F176L L177P ...     884/1072
(82 %)
27 diff
(97.5 %id)
BU174094 ductal carcinoma, cell line, Pancreas .a 41 to 916 1 to 886 S193L A194T P195T D196*     886/1024
(86 %)
20 diff
(98.1 %id)
BU168677 ductal carcinoma, cell line, Pancreas .a 41 to 761 1 to 723       723/928
(77 %)
6 diff
(99.4 %id)
BU180251 ductal carcinoma, cell line, Pancreas .a 41 to 673 1 to 633       633/1005
(62 %)
16 diff
(98.5 %id)
BU163633 ductal carcinoma, cell line, Pancreas .a 41 to 618 1 to 583       581/996
(58 %)
14 diff
(98.6 %id)
BU150001 ductal carcinoma, cell line, Pancreas .a 41 to 579 1 to 542       542/1118
(48 %)
12 diff
(99.0 %id)
BQ687294 ductal carcinoma, cell line, Pancreas .a 41 to 860 1 to 833       833/914
(91 %)
28 diff
(97.0 %id)
BQ689916 ductal carcinoma, cell line, Pancreas .a 41 to 859 1 to 824       824/875
(94 %)
8 diff
(99.1 %id)
BQ690026 ductal carcinoma, cell line, Pancreas .a 41 to 870 1 to 840 S166L A167C H168P F169L Q170S ...     840/883
(95 %)
19 diff
(97.9 %id)
BQ688151 ductal carcinoma, cell line, Pancreas .a 41 to 858 1 to 823       823/903
(91 %)
7 diff
(99.3 %id)
BQ689920 ductal carcinoma, cell line, Pancreas .a 41 to 761 1 to 726       726/912
(79 %)
7 diff
(99.3 %id)
BQ685490 ductal carcinoma, cell line, Pancreas .a 41 to 833 1 to 810       810/912
(88 %)
25 diff
(97.3 %id)
BQ685196 ductal carcinoma, cell line, Pancreas .a 41 to 908 1 to 883 H168P T174D P175T F176L L177S ...     883/965
(91 %)
27 diff
(97.3 %id)
BQ686162 ductal carcinoma, cell line, Pancreas .a 41 to 833 1 to 807       807/1001
(80 %)
10 diff
(99.1 %id)
BQ688690 ductal carcinoma, cell line, Pancreas .a 41 to 972 1 to 939 F176L L177P P178A F179L A180R ...     939/941
(99 %)
23 diff
(97.6 %id)
BM912017 amelanotic melanoma, cell line, skin .a 43 to 900 1 to 874 R110X K127X Q161P A162G S163Q ...     874/1097
(79 %)
36 diff
(96.8 %id)
BQ687842 ductal carcinoma, cell line, Pancreas .a 51 to 830 1 to 790       786/914
(85 %)
22 diff
(97.6 %id)
BM915681 amelanotic melanoma, cell line, skin .a 112 to 760 21 to 672       652/1148
(56 %)
20 diff
(98.3 %id)
BM562037 amelanotic melanoma, cell line, skin .a 113 to 976 1 to 873 A167G     873/1014
(86 %)
16 diff
(98.5 %id)
BM808325 amelanotic melanoma, cell line, skin .a 114 to 986 1 to 878 E154X D204H tiling clone,   878/1056
(83 %)
21 diff
(98.1 %id)
DB506061 hypothalamus .a 118 to 624 1 to 507       507/507
(100 %)
2 diff
(99.7 %id)
BI546631 brain, hippocampus .a 144 to 713 1 to 568       568/568
(100 %)
8 diff
(98.6 %id)
TI_44168908   .a 149 to 713 141 to 703       563/703
(80 %)
7 diff
(99.1 %id)
BG704160 brain, hippocampus .a 153 to 712 1 to 560       560/560
(100 %)
3 diff
(99.5 %id)
TI_154101326   .a 156 to 976 896 to 80 F12S I17S D24T E25K V30W ... AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 817/817
(100 %)
25 diff
(97.0 %id)
AW629796 2 pooled high-grade transitional celltumors, genitourinary tract .a 157 to 596 1 to 440       440/440
(100 %)
5 diff
(98.9 %id)
BU602132 mixed (pool of 40 RNAs) .a 162 to 837 1 to 685       685/832
(82 %)
17 diff
(98.0 %id)
CR623158 T cells (Jurkat cell line) Cot10-normalized .a 163 to 971 1 to 809 exact     809/809
(100 %)
0 diff
(100 %id)
BX345955   .a 163 to 957 1 to 793 A62Z K63X G111P R112E K113A ... fully sequenced, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 795/795
(100 %)
7 diff
(99.2 %id)
CR982372 T-Lymphocytes .a 163 to 963 1 to 801 E201X     801/801
(100 %)
1 diff
(99.9 %id)
CA772551 Pancreas, Purified pancreatic islet .a 164 to 864 11 to 711       701/711
(98 %)
7 diff
(99.1 %id)
BG165445 hypernephroma, cell line, Kidney .a 165 to 731 1 to 563       563/858
(65 %)
15 diff
(98.3 %id)
CN353363 embryonic stem cells, DMSO-treated H9 cellline .a 166 to 606 1 to 441       441/441
(100 %)
3 diff
(99.4 %id)
BG476216 melanotic melanoma, skin .a 166 to 904 1 to 738 E152G E153T E154R T155R S156H ...     709/844
(84 %)
28 diff
(96.7 %id)
BM555269 duodenal adenocarcinoma, cell line, small intestine .a 166 to 976 1 to 810 exact     810/1074
(75 %)
5 diff
(99.6 %id)
CB996836 placenta, pre-eclamptic placenta .a 167 to 430 21 to 284       264/314
(84 %)
6 diff
(98.1 %id)
CB989861 Human Placenta, placenta .a 170 to 831 28 to 692       665/834
(79 %)
15 diff
(98.3 %id)
CN353365 embryonic stem cells, cell lines H1, H7, andH9 .a 171 to 642 1 to 472       472/472
(100 %)
8 diff
(98.4 %id)
BQ216372 epithelioid carcinoma, Pancreas .a 173 to 912 1 to 748 G104R K129Q S193L A194R P195T ...     748/843
(88 %)
21 diff
(97.6 %id)
TI_57168547   .a 173 to 761 32 to 620       589/1200
(49 %)
14 diff
(98.9 %id)
CN353362 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 178 to 761 1 to 585       585/588
(99 %)
13 diff
(97.8 %id)
BM556027 amelanotic melanoma, cell line, skin .a 178 to 955 27 to 807 E154R P158T P160T Q161P A162G ...     781/1195
(65 %)
30 diff
(97.5 %id)
BM904652 leiomyosarcoma, uterus .a 178 to 835 10 to 669       660/1118
(59 %)
17 diff
(98.5 %id)
BM561293 amelanotic melanoma, cell line, skin .a 179 to 933 1 to 762 P189A P192A S193P A194Q P195H ...     762/969
(78 %)
13 diff
(98.7 %id)
TI_149290419   .a 179 to 957 851 to 78 K4X F12S P13R P14R A15R ... AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 774/808
(95 %)
17 diff
(97.9 %id)
BM705246 eye, RPE and Choroid .a 179 to 489 1 to 311   fully sequenced, Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 311/311
(100 %)
0 diff
(100 %id)
BI833133 pooled pancreas and spleen .a 180 to 761 1 to 583       583/1163
(50 %)
8 diff
(99.4 %id)
BI669164 brain, hypothalamus .a 180 to 904 1 to 716 Q161R A162P S163A H164T P165L ...     716/748
(95 %)
15 diff
(98.0 %id)
AA306760   .a 181 to 572 1 to 390       390/390
(100 %)
4 diff
(99.0 %id)
BM730113 insulinoma, Pancreas .a 183 to 609 1 to 427   fully sequenced, Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 427/427
(100 %)
3 diff
(99.3 %id)
BM857582 insulinoma, Pancreas .a 183 to 533 1 to 351   fully sequenced,   351/351
(100 %)
5 diff
(98.6 %id)
TI_57230902   .a 183 to 822 50 to 685       636/636
(100 %)
21 diff
(96.7 %id)
AA310481   .a 184 to 497 1 to 313       313/313
(100 %)
4 diff
(98.8 %id)
DB506055 hypothalamus .a 184 to 686 8 to 510       503/510
(98 %)
11 diff
(97.9 %id)
BE386666 melanotic melanoma, skin .a 184 to 851 1 to 660       660/765
(86 %)
28 diff
(96.4 %id)
CR987114 T-Lymphocytes .a 184 to 782 1 to 603       603/603
(100 %)
4 diff
(99.4 %id)
BM802406 duodenal adenocarcinoma, cell line, small intestine .a 185 to 933 1 to 753 P160T Q161P A162G S163Q H164A ...     753/1030
(73 %)
26 diff
(97.5 %id)
BU169803 large cell carcinoma, lung .a 185 to 932 1 to 763 S193L A194S P195T D196W E197M ...     763/858
(88 %)
20 diff
(97.7 %id)
TI_44346212   .a 185 to 904 85 to 795 Q161R A162P S163A H164T P165L ...     711/827
(85 %)
21 diff
(97.5 %id)
BF125522 melanotic melanoma, skin .a 186 to 625 1 to 440       440/440
(100 %)
3 diff
(99.4 %id)
BQ678105 melanotic melanoma, cell line, skin .a 186 to 586 1 to 402       402/900
(44 %)
3 diff
(99.7 %id)
AW834911 leiomios .a 189 to 404 1 to 215       215/215
(100 %)
2 diff
(99.1 %id)
BM760340 lymph node, stomach .a 189 to 779 1 to 591       591/591
(100 %)
0 diff
(100 %id)
BM760460 lymph node, stomach .a 189 to 369 1 to 181       181/181
(100 %)
0 diff
(100 %id)
BM840479 lymph node, stomach .a 189 to 719 1 to 531       531/531
(100 %)
0 diff
(100 %id)
BM841158 lymph node, stomach .a 189 to 668 1 to 480       480/480
(100 %)
0 diff
(100 %id)
BM841076 lymph node, stomach .a 189 to 558 1 to 370       370/370
(100 %)
0 diff
(100 %id)
BM840918 lymph node, stomach .a 189 to 710 1 to 522       522/522
(100 %)
6 diff
(98.9 %id)
BM841422 lymph node, stomach .a 189 to 673 1 to 487       485/489
(99 %)
3 diff
(99.4 %id)
TI_57228938   .a 190 to 761 87 to 661       575/580
(99 %)
5 diff
(99.2 %id)
BP219720 caudate nucleus .a 191 to 715 1 to 525       525/525
(100 %)
2 diff
(99.7 %id)
DN995811 breast cancer, Mammary gland (cancer tissue) .a 191 to 907 7 to 724 T155H S156X P158T P160T Q161P ...     718/724
(99 %)
9 diff
(98.8 %id)
BP211816 cerebrum .a 194 to 776 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP289281 lung .a 194 to 777 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
BP331794 renal proximal tubule .a 194 to 747 1 to 554       554/554
(100 %)
1 diff
(99.9 %id)
CN353366 embryonic stem cells, cell lines H1, H7, andH9 .a 195 to 927 13 to 748 T155H S156F Q157N P158K Q161P ...     736/748
(98 %)
12 diff
(98.4 %id)
BQ433469 epithelioid carcinoma, Pancreas .a 195 to 850 1 to 667       667/918
(72 %)
24 diff
(97.4 %id)
CN353364 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 196 to 741 1 to 547       547/547
(100 %)
2 diff
(99.7 %id)
BC010025 Muscle, rhabdomyosarcoma .a 197 to 957 1 to 761 exact available from MGC, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 761/761
(100 %)
0 diff
(100 %id)
BI045714 prostate_normal .a 197 to 720 4 to 524       521/533
(97 %)
15 diff
(97.2 %id)
BM271956 Pancreas, Purified pancreatic islet .a 197 to 733 1 to 536       536/536
(100 %)
1 diff
(99.9 %id)
BQ267679 insulinoma, Pancreas .a 197 to 656 8 to 467   fully sequenced, Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 460/467
(98 %)
6 diff
(98.8 %id)
BQ716552 sympathetic trunk .a 197 to 967 1 to 780 I27M G28W K29E V30G A31G ...     780/987
(79 %)
33 diff
(96.7 %id)
CA950615 Pancreas, Purified pancreatic islet .a 197 to 609 1 to 413   fully sequenced,   413/413
(100 %)
0 diff
(100 %id)
DB488584 hypothalamus .a 198 to 652 1 to 455       455/455
(100 %)
15 diff
(96.8 %id)
BG395819 eye, retinoblastoma .a 198 to 699 1 to 502       502/502
(100 %)
0 diff
(100 %id)
BU620949 cell lines, Chondrosarcoma .a 199 to 976 788 to 19 K7N Y8T N9T A10R R11V ... AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 770/834
(92 %)
11 diff
(98.7 %id)
BP235610 coronary artery .a 200 to 782 1 to 583       583/583
(100 %)
0 diff
(100 %id)
CD579844 brain .a 200 to 767 1 to 567       567/686
(82 %)
21 diff
(97.0 %id)
BM915209 amelanotic melanoma, cell line, skin .a 206 to 976 20 to 792 exact AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 773/792
(97 %)
12 diff
(98.5 %id)
DB504529 hypothalamus .a 208 to 684 1 to 478       476/478
(99 %)
3 diff
(99.4 %id)
AA325475 brain, cerebellum .a 210 to 459 1 to 250       250/257
(97 %)
7 diff
(97.3 %id)
TI_149303203   .a 213 to 976 848 to 85 L50X AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 764/954
(80 %)
6 diff
(99.4 %id)
BM888400 eye .a 214 to 493 1 to 280       280/280
(100 %)
4 diff
(98.6 %id)
CK824883 Pancreas, Purified pancreatic islet .a 217 to 804 1 to 588     Submitted on the opposite strand 588/588
(100 %)
0 diff
(100 %id)
AI904451 breast .a 218 to 535 19 to 336       318/348
(91 %)
11 diff
(96.9 %id)
BU619996 cell lines, Chondrosarcoma .a 222 to 976 769 to 19 K7N Y8T N9T A10R R11V ... AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 751/751
(100 %)
4 diff
(99.5 %id)
BM455830 lymph, lymphoma, cell line .a 224 to 978 1 to 757 exact     757/1065
(71 %)
7 diff
(99.4 %id)
CR997551 T-Lymphocytes .a 225 to 957 1 to 733 exact AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 733/733
(100 %)
0 diff
(100 %id)
AI879258 brain, frontal lobe .a 226 to 609 1 to 384   fully sequenced,   384/384
(100 %)
0 diff
(100 %id)
CR992069 T-Lymphocytes .a 226 to 969 1 to 746 exact     746/746
(100 %)
2 diff
(99.8 %id)
CN484068 eye .a 227 to 861 1 to 635       635/635
(100 %)
5 diff
(99.3 %id)
BI521420 pooled pancreas and spleen .a 227 to 761 1 to 531       531/537
(98 %)
8 diff
(98.6 %id)
BI522239 pooled pancreas and spleen .a 227 to 904 703 to 26 exact     678/703
(96 %)
1 diff
(99.9 %id)
BE961094 melanotic melanoma, high MDR, skin .a 231 to 582 1 to 351       351/909
(38 %)
9 diff
(99.1 %id)
BE265179 lung, small cell carcinoma .a 233 to 824 1 to 596       596/596
(100 %)
11 diff
(98.2 %id)
BG759184 B-cells, primary B-cells from tonsils (cell line) .a 244 to 870 1 to 630 P158T P159E Q161R A162P S163A ...     630/778
(80 %)
24 diff
(97.0 %id)
BQ420360 epithelioid carcinoma, Pancreas .a 247 to 978 1 to 732 exact     732/740
(98 %)
1 diff
(99.9 %id)
EL733476 mixed .a 248 to 865 1 to 616       616/678
(90 %)
15 diff
(97.8 %id)
BE907694 epithelioid carcinoma, Pancreas .a 249 to 750 1 to 499       499/509
(98 %)
7 diff
(98.7 %id)
CA775971 Pancreas, Purified pancreatic islet .a 250 to 957 708 to 1 exact     708/708
(100 %)
2 diff
(99.8 %id)
TI_1948099691   .a 250 to 681 129 to 560       432/461
(93 %)
7 diff
(98.5 %id)
TI_1948100211   .a 250 to 609 122 to 481   fully sequenced,   360/387
(93 %)
6 diff
(98.5 %id)
X96506   .a 250 to 957 1 to 708 exact AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 708/708
(100 %)
0 diff
(100 %id)
BM310705 Pancreas, Purified pancreatic islet .a 251 to 582 1 to 332       332/335
(99 %)
4 diff
(98.9 %id)
CA843207 Pancreas, Purified pancreatic islet .a 251 to 640 1 to 390   fully sequenced,   390/390
(100 %)
1 diff
(99.8 %id)
BF569429 Kidney, renal carcinoma (ascites) .a 254 to 761 1 to 507       507/1174
(43 %)
8 diff
(99.4 %id)
BG033049 breast, mammary adenocarcinoma, cell line .a 254 to 761 1 to 511       511/924
(55 %)
11 diff
(98.9 %id)
BQ014552 Chondrosarcoma, Left Pubic Bone .a 254 to 975 722 to 1       722/722
(100 %)
0 diff
(100 %id)
BU633271 cell lines, Chondrosarcoma .a 259 to 976 736 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 718/718
(100 %)
1 diff
(99.9 %id)
CB120245 Liver .a 269 to 753 1 to 485       485/485
(100 %)
0 diff
(100 %id)
CB119352 Liver .a 269 to 458 1 to 190       190/190
(100 %)
5 diff
(97.4 %id)
BQ218901 epithelioid carcinoma, Pancreas .a 270 to 899 1 to 636       636/955
(66 %)
18 diff
(98.2 %id)
BM841328 lymph node, stomach .a 272 to 587 1 to 318       318/318
(100 %)
7 diff
(97.8 %id)
CF129761 Chondrosarcoma Lung Metastasis cell lines, lung .a 276 to 392 11 to 127       117/127
(92 %)
6 diff
(95.3 %id)
TI_154192104   .a 277 to 976 50 to 749   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 700/700
(100 %)
0 diff
(100 %id)
CF130167 Chondrosarcoma Lung Metastasis cell lines, lung .a 278 to 948 1 to 671       671/671
(100 %)
0 diff
(100 %id)
BU621506 cell lines, Chondrosarcoma .a 278 to 993 735 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 717/722
(99 %)
2 diff
(99.8 %id)
BM811048 amelanotic melanoma, cell line, skin .a 280 to 973 1 to 694   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 694/697
(99 %)
5 diff
(99.3 %id)
BQ576079 Chondrosarcoma Grade II, Left Pelvis .a 283 to 986 722 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 704/704
(100 %)
1 diff
(99.9 %id)
AI991040 colon, colonic mucosa from 3 patients with Crohn'sdisease .a 285 to 976 701 to 3       699/718
(97 %)
10 diff
(98.7 %id)
BQ018240 lung, Metastatic Chondrosarcoma .a 285 to 973 691 to 3       689/708
(97 %)
3 diff
(99.6 %id)
BU631077 cell lines, Chondrosarcoma .a 285 to 975 691 to 1       691/704
(98 %)
2 diff
(99.8 %id)
BG113608 Bone, osteosarcoma, cell line .a 286 to 957 719 to 42   AAA Submitted on the opposite strand 678/748
(90 %)
28 diff
(96.3 %id)
AA554831 lung, lung tumor .a 295 to 978 691 to 8       684/691
(98 %)
22 diff
(96.9 %id)
U41843   .a 295 to 909 331 to 945       615/1024
(60 %)
7 diff
(99.4 %id)
BM981253 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 300 to 975 676 to 1       676/676
(100 %)
0 diff
(100 %id)
BU621371 cell lines, Chondrosarcoma .a 300 to 976 695 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 677/677
(100 %)
0 diff
(100 %id)
CF128923 Chondrosarcoma Lung Metastasis cell lines, lung .a 305 to 761 1 to 457       457/458
(99 %)
1 diff
(99.8 %id)
TI_154190521   .a 305 to 964 51 to 702       652/963
(67 %)
25 diff
(97.5 %id)
CA431373 cell lines, Enchondroma .a 305 to 976 690 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 672/672
(100 %)
0 diff
(100 %id)
CA422057 Bone, Enchondroma cell line .a 307 to 976 688 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 670/670
(100 %)
0 diff
(100 %id)
BM973417 lung .a 308 to 957 668 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 650/650
(100 %)
4 diff
(99.4 %id)
BP338729 Spleen .a 309 to 873 1 to 565       565/565
(100 %)
2 diff
(99.7 %id)
EL593341 epidermis, skin .a 310 to 464 19 to 173       155/186
(83 %)
9 diff
(95.2 %id)
TI_154110291   .a 314 to 976 726 to 64   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 663/995
(66 %)
1 diff
(99.9 %id)
CA448044 Chondrosarcoma, Left Pubic Bone .a 314 to 975 662 to 1       662/674
(98 %)
1 diff
(99.9 %id)
CF129614 Chondrosarcoma Lung Metastasis cell lines, lung .a 317 to 911 1 to 595       595/595
(100 %)
0 diff
(100 %id)
TI_154191354   .a 317 to 976 51 to 711   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 661/661
(100 %)
1 diff
(99.9 %id)
CN353361 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 320 to 842 1 to 525       525/525
(100 %)
3 diff
(99.5 %id)
BF345953 anaplastic oligodendroglioma with 1p/19qloss, brain .a 328 to 566 1 to 239       239/239
(100 %)
0 diff
(100 %id)
CF130604 Chondrosarcoma Lung Metastasis cell lines, lung .a 331 to 977 1 to 647       647/647
(100 %)
0 diff
(100 %id)
TI_154192602   .a 331 to 983 51 to 704       654/655
(99 %)
2 diff
(99.7 %id)
AI908006 breast .a 333 to 571 1 to 240       240/242
(99 %)
3 diff
(98.8 %id)
AI907999 breast .a 334 to 735 440 to 34       407/440
(92 %)
12 diff
(97.3 %id)
BQ686200 ductal carcinoma, cell line, Pancreas .a 335 to 976 1 to 642   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 642/642
(100 %)
0 diff
(100 %id)
AA421977 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 340 to 703 1 to 358   fully sequenced, Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 360/360
(100 %)
4 diff
(98.9 %id)
BU630051 cell lines, Chondrosarcoma .a 340 to 976 655 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 637/637
(100 %)
0 diff
(100 %id)
BU617822 cell lines, Chondrosarcoma .a 357 to 957 618 to 18   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 601/601
(100 %)
1 diff
(99.9 %id)
C03419 heart .a 363 to 688 8 to 338       331/346
(95 %)
9 diff
(97.4 %id)
C04859 heart .a 363 to 579 7 to 223       217/227
(95 %)
6 diff
(97.4 %id)
C04874 heart .a 363 to 605 8 to 248       241/255
(94 %)
6 diff
(97.7 %id)
AW800145 uterus .a 366 to 535 171 to 1       171/181
(94 %)
5 diff
(97.3 %id)
BE876461 large cell carcinoma, undifferentiated, lung .a 372 to 761 1 to 391       391/457
(85 %)
6 diff
(98.7 %id)
AA331368   .a 382 to 487 1 to 107       107/107
(100 %)
4 diff
(96.3 %id)
BI870962 adenocarcinoma, cell line, Liver .a 397 to 720 1 to 324       324/489
(66 %)
8 diff
(98.4 %id)
BQ574829 Chondrosarcoma Grade II, Left Pelvis .a 405 to 976 590 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 572/581
(98 %)
0 diff
(100 %id)
BG996531 head_neck .a 407 to 728 326 to 8       319/326
(97 %)
1 diff
(99.7 %id)
BG988462 head_neck .a 418 to 835 434 to 18       417/434
(96 %)
1 diff
(99.8 %id)
BU602071 mixed (pool of 40 RNAs) .a 426 to 990 1 to 566       566/569
(99 %)
10 diff
(98.3 %id)
BM007136 ductal carcinoma, cell line, Pancreas .a 428 to 904 479 to 1   fully sequenced,   479/479
(100 %)
2 diff
(99.6 %id)
BM006935 ductal carcinoma, cell line, Pancreas .a 428 to 904 516 to 28   fully sequenced,   489/516
(94 %)
9 diff
(98.3 %id)
TI_59395311   .a 428 to 904 479 to 1   fully sequenced,   479/479
(100 %)
2 diff
(99.6 %id)
TI_59395821   .a 428 to 904 516 to 28   fully sequenced,   489/516
(94 %)
9 diff
(98.3 %id)
CK825215 Pancreas, Purified pancreatic islet .a 429 to 966 538 to 1     Submitted on the opposite strand 538/538
(100 %)
2 diff
(99.7 %id)
AA702425 liver and spleen .a 433 to 957 524 to 1       524/527
(99 %)
6 diff
(98.9 %id)
AV726768 hypothalamus .a 437 to 976 10 to 549   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 540/549
(98 %)
8 diff
(98.6 %id)
BM264586 Pancreas, Purified pancreatic islet .a 438 to 956 519 to 1       519/530
(97 %)
16 diff
(97.0 %id)
BQ018267 lung, Metastatic Chondrosarcoma .a 438 to 988 569 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 551/555
(99 %)
2 diff
(99.7 %id)
CA434302 lung, Metastatic Chondrosarcoma .a 438 to 988 569 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 551/555
(99 %)
2 diff
(99.7 %id)
BU736817 eye, RPE and Choroid .a 441 to 976 554 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 536/536
(100 %)
0 diff
(100 %id)
TI_154091071   .a 451 to 988 621 to 84   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 538/871
(61 %)
5 diff
(99.5 %id)
BE698358 uterus_tumor .a 459 to 722 23 to 286       264/286
(92 %)
6 diff
(98.0 %id)
AA477052 ovarian tumor, ovary .a 459 to 703 2 to 244   fully sequenced,   245/246
(99 %)
1 diff
(99.6 %id)
DB575769 hypothalamus .a 467 to 957 1 to 491     Submitted on the opposite strand 491/491
(100 %)
2 diff
(99.6 %id)
BQ021466 lung, Metastatic Chondrosarcoma .a 474 to 976 521 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 503/503
(100 %)
3 diff
(99.5 %id)
BM994482 lung, Metastatic Chondrosarcoma .a 474 to 976 521 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 503/503
(100 %)
3 diff
(99.5 %id)
AA633265 colon, colon tumor RER+ .a 480 to 956 475 to 1       475/475
(100 %)
5 diff
(99.0 %id)
AI864295 pooled .a 491 to 978 493 to 4       490/500
(98 %)
9 diff
(98.2 %id)
AI078778 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 493 to 976 484 to 1       484/484
(100 %)
0 diff
(100 %id)
AI282816 esophagus, squamous cell carcinoma .a 493 to 957 465 to 1       465/465
(100 %)
6 diff
(98.8 %id)
AI434915 lymph node, lymphoma, follicular mixed small and largecell .a 493 to 957 464 to 1       464/464
(100 %)
4 diff
(99.2 %id)
AI246215 follicular lymphoma, lymph node .a 497 to 958 462 to 1       462/462
(100 %)
0 diff
(100 %id)
DB577364 hypothalamus .a 499 to 976 1 to 481     Submitted on the opposite strand 481/481
(100 %)
8 diff
(98.4 %id)
BU615642 Bone, Enchondroma cell line .a 499 to 990 510 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 492/492
(100 %)
0 diff
(100 %id)
AI274869 adenocarcinoma, colon .a 502 to 962 459 to 1       459/459
(100 %)
8 diff
(98.3 %id)
DB577371 hypothalamus .a 503 to 988 1 to 486     Submitted on the opposite strand 486/486
(100 %)
3 diff
(99.4 %id)
BM857466 insulinoma, Pancreas .a 503 to 945 443 to 1   fully sequenced,   443/443
(100 %)
2 diff
(99.6 %id)
BE905105 epithelioid carcinoma, Pancreas .a 511 to 759 1 to 248       248/297
(83 %)
7 diff
(97.7 %id)
AV704488 adrenal gland .a 515 to 957 1 to 443   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 443/443
(100 %)
0 diff
(100 %id)
AA716030 pineal gland .a 517 to 957 442 to 1       442/442
(100 %)
11 diff
(97.6 %id)
AI356116 brain, glioblastoma (pooled) .a 517 to 969 453 to 1       453/453
(100 %)
2 diff
(99.6 %id)
BM930698 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 522 to 993 1 to 471   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 471/471
(100 %)
1 diff
(99.8 %id)
AW157437 brain, frontal lobe .a 524 to 978 460 to 6       455/460
(98 %)
1 diff
(99.8 %id)
AI565641 anaplastic oligodendroglioma, brain .a 529 to 976 448 to 1       448/448
(100 %)
3 diff
(99.4 %id)
BM988095 mixed .a 531 to 975 445 to 1       445/445
(100 %)
0 diff
(100 %id)
DB558586 hypothalamus .a 534 to 976 1 to 441     Submitted on the opposite strand 439/441
(99 %)
19 diff
(95.7 %id)
AA641399 epithelium (cell line), Prostate .a 534 to 825 290 to 1       290/290
(100 %)
4 diff
(98.7 %id)
AA157986 Pancreas .a 539 to 977 445 to 1       445/445
(100 %)
12 diff
(97.4 %id)
AA714119 synovial sarcoma .a 539 to 957 423 to 1       423/423
(100 %)
27 diff
(93.7 %id)
TI_59392518   .a 539 to 920 86 to 469       384/384
(100 %)
9 diff
(97.7 %id)
DB557915 hypothalamus .a 540 to 976 1 to 427     Submitted on the opposite strand 427/428
(99 %)
26 diff
(94.0 %id)
BM014490 breast, mammary adenocarcinoma, cell line .a 540 to 920 1 to 383       383/383
(100 %)
9 diff
(97.7 %id)
AW003864 brain, glioblastoma (pooled) .a 541 to 862 322 to 1       322/322
(100 %)
23 diff
(92.9 %id)
BP387250 pancreatic islet .a 545 to 950 1 to 408     Submitted on the opposite strand 408/410
(99 %)
3 diff
(99.3 %id)
BP386921 pancreatic islet .a 546 to 936 1 to 394     Submitted on the opposite strand 394/394
(100 %)
8 diff
(98.0 %id)
AI076130 liver and spleen .a 546 to 976 431 to 1       431/431
(100 %)
0 diff
(100 %id)
AI042141 senescent fibroblast .a 547 to 969 437 to 15   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 423/423
(100 %)
5 diff
(98.9 %id)
AI879639 brain, frontal lobe .a 548 to 847 300 to 1   fully sequenced,   300/300
(100 %)
3 diff
(99.0 %id)
BM511762 insulinoma, Pancreas .a 548 to 957 425 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 410/410
(100 %)
0 diff
(100 %id)
CA950374 Pancreas, Purified pancreatic islet .a 548 to 956 409 to 1   fully sequenced,   409/409
(100 %)
0 diff
(100 %id)
TI_1948100212   .a 548 to 866 445 to 127   fully sequenced,   319/445
(71 %)
0 diff
(100 %id)
AI468015 pooled .a 550 to 976 442 to 16   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 427/428
(99 %)
1 diff
(99.8 %id)
AI076140 liver and spleen .a 553 to 978 426 to 1       426/426
(100 %)
1 diff
(99.8 %id)
AA075358   .a 556 to 946 1 to 397   fully sequenced,   397/397
(100 %)
15 diff
(96.3 %id)
BM691567 eye, RPE and Choroid .a 561 to 978 1 to 418   fully sequenced, Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 418/418
(100 %)
9 diff
(97.9 %id)
AI831031 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 563 to 1006 443 to 2   tiling clone,   442/445
(99 %)
11 diff
(97.6 %id)
AI753931 bone marrow stroma .a 573 to 976 422 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 404/404
(100 %)
0 diff
(100 %id)
AA293686 ovarian tumor, ovary .a 575 to 732 1 to 159   fully sequenced,   159/159
(100 %)
1 diff
(99.4 %id)
BX112529 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 579 to 830 1 to 253       251/253
(99 %)
5 diff
(98.1 %id)
AA992074   .a 579 to 978 401 to 2       400/409
(97 %)
0 diff
(100 %id)
BG120171 adenocarcinoma, cell line, Liver .a 579 to 976 1 to 399   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 399/399
(100 %)
1 diff
(99.8 %id)
AA431568   .a 593 to 862 271 to 1       271/271
(100 %)
12 diff
(95.6 %id)
EL952590 eyeball .a 598 to 976 424 to 47   AAA Submitted on the opposite strand 378/378
(100 %)
3 diff
(99.3 %id)
AI201819 anaplastic oligodendroglioma, brain .a 601 to 957 357 to 1       357/357
(100 %)
0 diff
(100 %id)
BQ017470 lung, Metastatic Chondrosarcoma .a 603 to 986 402 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 384/384
(100 %)
9 diff
(97.7 %id)
AI424212 brain, glioblastoma (pooled) .a 604 to 969 364 to 1       364/364
(100 %)
2 diff
(99.5 %id)
BQ013223 placenta .a 604 to 975 372 to 1       372/372
(100 %)
1 diff
(99.8 %id)
CA433610 mixed .a 606 to 957 370 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 352/352
(100 %)
0 diff
(100 %id)
CA843959 Pancreas, Purified pancreatic islet .a 610 to 957 348 to 1   fully sequenced,   348/348
(100 %)
5 diff
(98.6 %id)
BM836007 stomach .a 622 to 794 1 to 173       173/173
(100 %)
0 diff
(100 %id)
EC560711 Prostate .a 623 to 723 1 to 102       102/102
(100 %)
3 diff
(97.1 %id)
EC485345 Prostate .a 624 to 723 1 to 97       97/97
(100 %)
4 diff
(95.9 %id)
BQ272289 insulinoma, Pancreas .a 626 to 976 366 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 351/351
(100 %)
3 diff
(99.2 %id)
F37452 pectoral muscle (after mastectomy) .a 626 to 978 1 to 353       353/359
(98 %)
1 diff
(99.8 %id)
AA382349 testis .a 628 to 877 1 to 250       250/250
(100 %)
1 diff
(99.6 %id)
AI365260 pooled germ cell tumors .a 628 to 976 373 to 26   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 348/348
(100 %)
21 diff
(94.0 %id)
AA922752 pooled germ cell tumors .a 634 to 976 343 to 1       343/343
(100 %)
5 diff
(98.6 %id)
TI_154019594   .a 637 to 988 447 to 95   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 353/686
(51 %)
3 diff
(99.6 %id)
CA438010 lung, Metastatic Chondrosarcoma .a 637 to 988 371 to 19   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 353/357
(98 %)
3 diff
(99.2 %id)
BX345954   .a 642 to 906 265 to 1   fully sequenced, Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 265/265
(100 %)
1 diff
(99.7 %id)
AA476942 ovarian tumor, ovary .a 642 to 977 336 to 1   fully sequenced,   336/336
(100 %)
3 diff
(99.2 %id)
AA406285 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 642 to 976 348 to 14   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 335/335
(100 %)
3 diff
(99.2 %id)
AI123247 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 649 to 991 343 to 1       343/343
(100 %)
0 diff
(100 %id)
AA393753.
matches multiple genes
  .a 652 to 952 10 to 308     also hits gene warga 299/308
(97 %)
15 diff
(95.2 %id)
AA722121 pineal gland .a 655 to 978 324 to 1       324/324
(100 %)
10 diff
(97.0 %id)
AA075359   .a 681 to 958 278 to 1   fully sequenced,   278/278
(100 %)
2 diff
(99.3 %id)
AA435785   .a 688 to 957 270 to 1       270/270
(100 %)
2 diff
(99.3 %id)
AI125945 uterus .a 693 to 978 286 to 1       286/286
(100 %)
3 diff
(99.0 %id)
AI375209 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 693 to 978 286 to 1       286/286
(100 %)
0 diff
(100 %id)
AA398455 ovarian tumor, ovary .a 702 to 978 278 to 2   fully sequenced,   277/278
(99 %)
1 diff
(99.7 %id)
BM662461 eye, RPE and Choroid .a 702 to 957 273 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 256/256
(100 %)
1 diff
(99.7 %id)
AA401120 ovarian tumor, ovary .a 705 to 864 1 to 160   fully sequenced,   160/160
(100 %)
6 diff
(96.3 %id)
CB050175 Prostate .a 705 to 976 297 to 26   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 272/278
(97 %)
1 diff
(99.7 %id)
F15607 pectoral muscle (after mastectomy) .a 708 to 976 1 to 268       268/270
(99 %)
8 diff
(97.1 %id)
BP393764 pancreatic islet .a 715 to 976 1 to 264     Submitted on the opposite strand 264/264
(100 %)
6 diff
(97.8 %id)
AA573275 colon .a 721 to 862 142 to 1       142/142
(100 %)
3 diff
(97.9 %id)
AW449544   .a 721 to 957 254 to 18   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 237/238
(99 %)
3 diff
(98.8 %id)
N72154 melanocyte .a 723 to 978 262 to 7       256/262
(97 %)
1 diff
(99.7 %id)
AV706925 adrenal gland .a 724 to 957 1 to 234   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 234/234
(100 %)
1 diff
(99.6 %id)
BF439812 pooled .a 726 to 978 254 to 2       253/262
(96 %)
1 diff
(99.7 %id)
AA401121 ovarian tumor, ovary .a 731 to 862 132 to 1   fully sequenced,   132/132
(100 %)
1 diff
(99.3 %id)
BM685234 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 731 to 993 281 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 263/263
(100 %)
0 diff
(100 %id)
CB111185 Liver .a 734 to 957 1 to 224   AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 224/224
(100 %)
1 diff
(99.6 %id)
BE857736 Prostate .a 741 to 977 237 to 1       237/237
(100 %)
3 diff
(98.8 %id)
AA372238 epithelium, retina pigmented layer .a 784 to 977 194 to 1     Submitted on the opposite strand 194/194
(100 %)
0 diff
(100 %id)
BF031033 hypernephroma, Kidney .a 788 to 969 1 to 179       179/179
(100 %)
3 diff
(98.4 %id)
AV752683 Pituitary .b 1 to 619 1 to 617 W2V A43C A44V V45L P46V ... tiling clone,   614/786
(78 %)
32 diff
(96.0 %id)
BU932959 mixed (pool of 40 RNAs) .c 1 to 635 1 to 643 P158S D182E E183R E184R D185R ... tiling clone,   643/854
(75 %)
21 diff
(97.6 %id)
TI_154190986   .c 25 to 678 50 to 703   tiling clone, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 654/654
(100 %)
0 diff
(100 %id)
CF129301 Chondrosarcoma Lung Metastasis cell lines, lung .c 26 to 633 1 to 608       608/608
(100 %)
0 diff
(100 %id)
BP421215 small intestine .d 1 to 501 1 to 503   tiling clone, Submitted on the opposite strand 503/503
(100 %)
6 diff
(98.9 %id)
BM559850 amelanotic melanoma, cell line, skin .d 21 to 730 1 to 710 exact     710/1106
(64 %)
5 diff
(99.6 %id)
BM911565 amelanotic melanoma, cell line, skin .d 22 to 733 1 to 712 exact tiling clone,   712/743
(95 %)
1 diff
(99.9 %id)
CA423339 cell lines, Chondrosarcoma .d 37 to 742 726 to 19 L26X S161X tiling clone, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 708/708
(100 %)
8 diff
(98.9 %id)
BM471527 leiomyosarcoma, uterus .e 1 to 615 1 to 619 R157T W158V D159G G160W N161E ... tiling clone,   619/1232
(50 %)
10 diff
(99.2 %id)
BU181320 large cell carcinoma, lung .e 580 to 1361 788 to 1   tiling clone, Submitted on the opposite strand 788/937
(84 %)
10 diff
(99.0 %id)
AW235510 hepatic adenoma, Liver .e 749 to 1222 474 to 1       474/474
(100 %)
1 diff
(99.8 %id)
CN299511 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 1 to 618 1 to 618   tiling clone,   618/618
(100 %)
0 diff
(100 %id)
BE616679 adenocarcinoma, Pancreas .f 11 to 672 8 to 678       669/697
(95 %)
25 diff
(96.5 %id)
CN299510 embryonic stem cells, cell lines H1, H7, andH9 .f 124 to 397 1 to 274       274/274
(100 %)
1 diff
(99.7 %id)
BU619463 cell lines, Chondrosarcoma .f 261 to 887 645 to 19 exact tiling clone, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 627/627
(100 %)
0 diff
(100 %id)
BX352797 Neuroblastoma Cot 10-normalized .f 266 to 850 586 to 1 exact     586/602
(97 %)
5 diff
(99.2 %id)
AI627256 Kidney .f 275 to 849 575 to 1 S102F S117F     575/575
(100 %)
4 diff
(99.4 %id)
AI563938 anaplastic oligodendroglioma, brain .f 276 to 868 593 to 1 exact     593/639
(92 %)
3 diff
(99.6 %id)
CK824884 Pancreas, Purified pancreatic islet .f 276 to 824 549 to 1 exact   Submitted on the opposite strand 549/549
(100 %)
0 diff
(100 %id)
BQ001944 lung, Metastatic Chondrosarcoma .f 276 to 887 630 to 19 S80F S102F S117F AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 612/612
(100 %)
6 diff
(99.1 %id)
AW085607 esophagus, squamous cell carcinoma .f 277 to 869 594 to 1 F16S V23G A24H S25P E34V ...     594/613
(96 %)
23 diff
(96.3 %id)
BQ773919 Chondrosarcoma Grade II, Left Pelvis .f 278 to 919 660 to 19 S102F S117F tiling clone, AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 642/642
(100 %)
7 diff
(99.0 %id)
BM310408 Pancreas, Purified pancreatic islet .f 281 to 867 587 to 1 T2P S4P H5P Q15H D21A ...     587/587
(100 %)
19 diff
(96.8 %id)
BE907784 epithelioid carcinoma, Pancreas .f 289 to 718 1 to 426       426/428
(99 %)
9 diff
(97.9 %id)
BG705646 brain, hypothalamus .f 290 to 735 1 to 443       443/489
(90 %)
5 diff
(99.0 %id)
DB489213 hypothalamus .f 299 to 756 1 to 457       457/457
(100 %)
16 diff
(96.5 %id)
AI828997 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .f 309 to 886 579 to 2 L6W P50Q T85X E89K T91X ...     578/580
(99 %)
8 diff
(98.7 %id)
BU629230 cell lines, Chondrosarcoma .f 309 to 901 611 to 19 S80F S102F S117F AAA Possibly primed on the genome, locally A rich (15/16 A in genome downstream of last aligned base) 593/593
(100 %)
5 diff
(99.2 %id)
CA441816 Chondrosarcoma, Left Pubic Bone .f 311 to 886 576 to 1 exact     576/576
(100 %)
0 diff
(100 %id)
AA641261 invasive tumor (cell line), Prostate .g 1 to 422 420 to 1 I2F Q7K D9A V15L A17P ... tiling clone,   420/420
(100 %)
21 diff
(95.0 %id)
BQ051920 blood, natural killer cells, cell line .h 1 to 746 1 to 751 H101P F102L Q103S S104K T107D ... tiling clone,   751/1071
(70 %)
21 diff
(98.1 %id)
BG176759 lymph, lymphoma, cell line .i-u 1 to 197 1 to 196 exact tiling clone,   196/196
(100 %)
1 diff
(99.5 %id)
BG036132 adenocarcinoma, cell line, Liver .i-u 25 to 197 1 to 173       173/173
(100 %)
0 diff
(100 %id)
BG114667 duodenal adenocarcinoma, cell line, small intestine .i-u 60 to 197 1 to 138       138/138
(100 %)
0 diff
(100 %id)
BG109745 Bone, osteosarcoma, cell line .i-u 121 to 197 1 to 76       76/76
(100 %)
1 diff
(98.7 %id)
BF341739 brain, glioblastoma with EGFR amplification .i-u 145 to 197 1 to 53       53/53
(100 %)
0 diff
(100 %id)
BU567043 mixed (pool of 40 RNAs) .i-u 147 to 250 1 to 104   tiling clone, AAA   104/104
(100 %)
1 diff
(99.1 %id)
AI348015 adenocarcinoma, colon Gene DRAP1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI